NEW QIAstat-Dx Respiratory 2019-nCoV Panel

NEW QIAstat-Dx Respiratory 2019-nCoV Panel

Molecular Diagnostics / Molecular Biology

December 18, 2020

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel. This version of our multiplex syndromic cartridge detects and differentiates 22 respiratory targets, including 2019-nCoV (SARS-CoV-2).

  • Includes 2 molecular targets specific to 2019-nCoV: ORF1b gene recommended by the Chinese Center for Disease Control and Prevention, and the E gene recommended by the US Centers for Disease Control and Prevention
  • Less than 1 minute hands-on time
  • Time to result: approximately 1 hour
 AFNOR Validation for SNAPduo ST Plus

AFNOR Validation for SNAPduo ST Plus

Molecular Diagnostics / Molecular Biology

IDEXX SnapDuo ST Plus has received an AFNOR Validation.
AFNOR Certification, obtained after rigorous validation and European ring trials, confirms the exceptional performance and robustness of the SNAPduo ST Plus test:

January 29, 2021 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us